MBX Biosciences is a preclinical-stage biotech company committed to creating therapies to treat rare endocrine diseases where there is inadequate treatment available.

MBX’s leadership team has collaborated successfully over several decades to discover, develop and commercialize first-in-class endocrine therapeutics. A distinguishing strength of MBX is world-class proprietary peptide drug discovery.

Biotechnology

Education

MBX Biosciences

MBX Biosciences' headquarters in Carmel, IN, United States

Kent Hawryluk

Chatan Charan

Karen Basbaum

Mark Hope

Mary Jane Geiger

Richard Bartram

Debra Sojka

Michael A. Dorato

Director, Discovery Pharmacology

Vice President, Quality

Michelle Graham

Matt Gambino

Patrick Heron

Ed Mathers

Jim Cornelius

Carl L. Gordon

Ora Pescovitz

Tiba Aynechi

The Directors and Vice Presidents at MBX Biosciences are responsible for overseeing and guiding various departments and strategic initiatives critical to the company’s mission. Their roles include leading drug discovery and development, managing pharmacology and toxicology studies, steering project management for chemistry, manufacturing, and controls (CMC), and driving marketing and talent acquisition efforts. Collectively, they ensure that MBX Biosciences effectively advances its pipeline of innovative endocrine therapeutics from preclinical stages to commercialization.

Directors and Vice Presidents

This department oversees operations related to clinical development, regulatory compliance, and pharmacovigilance.

Clinical Affairs

The Leadership Team at MBX Biosciences plays a pivotal role in steering the company toward its goal of developing innovative therapies for rare endocrine diseases. Comprising seasoned executives with extensive industry experience, this team focuses on strategic decision-making, regulatory navigation, and fostering collaboration to advance the discovery and commercialization of first-in-class peptide therapeutics, ensuring that the company remains at the forefront of biotech innovation.

Leadership Team

The Regulatory and Clinical Team at MBX Biosciences is responsible for overseeing the development and execution of clinical trials, ensuring compliance with global regulatory requirements, and guiding the approval processes for new therapies. This team plays a critical role in translating MBX's innovative peptide drug discoveries into viable treatments for rare endocrine diseases by coordinating with regulatory bodies and managing clinical operations to meet the highest standards of safety and efficacy.

Regulatory and Clinical Team

This department oversees the planning, implementation, and management of clinical trials and the overall clinical development process.

Clinical Operations

The Financial Team at MBX Biosciences oversees financial strategy and operations, ensuring robust financial planning, accurate accounting, and effective budgeting. They manage financial reporting, audit compliance, and provide insights to support strategic decision-making, enabling the company to advance its mission of developing groundbreaking therapies for rare endocrine diseases.

MBX Biosciences

Org chart

Board & advisors

Teams

Directors and Vice Presidents

Clinical Affairs

Leadership Team

Regulatory and Clinical Team

Clinical Operations

Financial Team

Offices

MBX Biosciences

Org chart

Board & advisors

Teams

Directors and Vice Presidents

Clinical Affairs

Leadership Team

Regulatory and Clinical Team

Clinical Operations

Financial Team

Offices

Related companies